| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |